Thyroid Gland Disorder Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

Thyroid Gland Disorder Treatment Trends and Forecast

The future of the global thyroid gland disorder treatment market looks promising with opportunities in the hypothyroidism and hyperthyroidism markets. The global thyroid gland disorder treatment market is expected to reach an estimated $3.06 billion by 2030 with a CAGR of 3.5% from 2024 to 2030. The major drivers for this market are rising prevalence of thyroid disorders, growing demand for personalized medicine, and increasing number of disease awareness programs in the developing countries.

A more than 150-page report is developed to help in your business decisions.

Thyroid Gland Disorder Treatment by Segment

The study includes a forecast for the global thyroid gland disorder treatment by route of administration, drug type, disease type, and region.

Thyroid Gland Disorder Treatment Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Oral
• Intravenous Route
• Others

Thyroid Gland Disorder Treatment Market by Drug Type [Shipment Analysis by Value from 2018 to 2030]:

• Levothyroxine
• Liothyronine
• Propylthiouracil
• Imidazole-Based Compounds
• Others

Thyroid Gland Disorder Treatment Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

• Hypothyroidism
• Hyperthyroidism

Thyroid Gland Disorder Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Thyroid Gland Disorder Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies thyroid gland disorder treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thyroid gland disorder treatment companies profiled in this report include-

• AbbVie
• Pfizer
• Merck
• Lannett Company
• Allergan
• Mylan
• GlaxoSmithKline
• Novartis
• RLC LABS
• Abbott Laboratories

Thyroid Gland Disorder Treatment Market Insights

The report forecasts that oral will remain the larger segment over the forecast period due to the fact that the medicines available on the market are tablets or pills, which can be easily administered every day by a patient.
Within this market, hypothyroidism will remain the larger segment due to rising incidence of iodine deficiency worldwide.
North America will remain the largest region over the forecast period due to growing prevalence of thyroid diseases, new product launches and approvals, and strong concentration of market players.

Features of the Global Thyroid Gland Disorder Treatment Market

• Market Size Estimates: Thyroid gland disorder treatment market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
• Segmentation Analysis: Thyroid gland disorder treatment market size by route of administration, drug type, disease type, and region in terms of value ($B).
• Regional Analysis: Thyroid gland disorder treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different route of administration, drug types, disease types, and regions for the thyroid gland disorder treatment market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the thyroid gland disorder treatment market.
• Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQs

Q1. What is the thyroid gland disorder treatment market size?
Answer: The global thyroid gland disorder treatment market is expected to reach an estimated $3.06 billion by 2030.

Q2. What is the growth forecast for thyroid gland disorder treatment market?
Answer: The global thyroid gland disorder treatment market is expected to grow with a CAGR of 3.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the thyroid gland disorder treatment market?
Answer: The major drivers for this market are rising prevalence of thyroid disorders, growing demand for personalized medicine, and increasing number of disease awareness programs in the developing countries.

Q4. What are the major segments for thyroid gland disorder treatment market?
Answer: The future of the thyroid gland disorder treatment market looks promising with opportunities in the hypothyroidism and hyperthyroidism markets.

Q5. Who are the key thyroid gland disorder treatment market companies?

Answer: Some of the key thyroid gland disorder treatment companies are as follows:

• AbbVie
• Pfizer
• Merck
• Lannett Company
• Allergan
• Mylan
• GlaxoSmithKline
• Novartis
• RLC LABS
• Abbott Laboratories

Q6. Which thyroid gland disorder treatment market segment will be the largest in future?
Answer: The report forecasts that oral will remain the larger segment over the forecast period due to the fact that the medicines available on the market are tablets or pills, which can be easily administered every day by a patient.

Q7. In thyroid gland disorder treatment market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to growing prevalence of thyroid diseases, new product launches and approvals, and strong concentration of market players.

Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the thyroid gland disorder treatment market by route of administration (oral, intravenous route, and others), drug type (levothyroxine, liothyronine, propylthiouracil, imidazole-based compounds, and others), disease type (hypothyroidism and hyperthyroidism), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?


This product will be delivered within 1-3 business days.